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Background
Liposarcomas (LPS) are rare tumors accounting approxi-
mately for 19% of adult soft-tissue tumors [1]. The most
recent classification of the WHO divides liposarcomas
into 3 main clinicopatological and genetic subtypes:
myxoid/round cells liposarcoma, well differentiated /
dedifferentiated liposarcoma and pleomorphic liposar-
coma [2]. The importance of a total macroscopical
resection to perform an oncologically correct operation
is well known, so that it is often necessary to remove
one or more adjoining organs with the purpose of redu-
cing the risk of local secondary recurrences [3].
Materials and methods
We present the case of an 88-year-old woman with a
large abdominal swelling. The TC of the abdomen
shows the spleen moved upward (Figure. 1). The left
hemiabdomen is filled by an expansive formation almost
20 cm wide in diameter, made partly of a solid compo-
nent and partly cystic-like. The pancreas is totally
against the gallbladder. It does not seem possible to
remove the back wall of the spleen from the swelling.
(Figure 2).
We decide to perform surgery. The neoplasia is in
continuity with the tail of the pancreas, so a distal pan-
creasectomy and splenectomy is performed. Definitive
histological examination: dedifferentiated liposarcoma of
high degree.
Results
After surgical resection of the primitive liposarcoma,
factors determining the probability of recurrence and
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© 2010 Amodeo et al; licensee BioMed Central Ltd.survival are: histological type, the impossibility to
perform a complete resection, the removal of adjoining
organs and the advanced age [4].
Conclusions
In retroperitoneal and abdominal lesions surgical treat-
ment remains the most important therapy because of
the evident lack of benefit of chemotherapy and the
impossibility to administer doses suitable of radiation
without serious damag to the healthy tissues. Studies are
in progress for the revaluation of intraoperative radio-
therapy (IORT) and of preoperative chemotherapy.
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